SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jef saunders who wrote (3250)2/3/2000 6:46:00 AM
From: Mark Bartlett  Read Replies (2) of 14101
 
Jeff,

<<.i thought the WF-10 study was at a lot of places in the united states>>

It is, but as a Phase III drug for AIDS, although the lymphoma trials are going down there too, come to think of it.

Interestingly, there was a fellow at the 1998 AGM that had primary cancer of the liver and he was put on the terminal list. He took WF10 as a last resort. I talked with him for a while after the meeting. He said that he felt no untoward side effects; he just had a flushed feeling of warmth when the WF10 was infused.

He said that his tumour shrank and appeared to stop growing. Never went away completely. Said he felt really good. Bottom line for him -- he was not supposed to be around for the AGM, had no interest in the company as a shareholder, and only attended to relate his personal experience.

There have been other anecdotal stories of cancer treatment success too. I know that it has been used successfully for prostate and one form of bone cancer, again in anecdotal instances.

WF10 will not be the answer to every cancer, but there does appear to be enough evidence that it has a positive impact on some.

MB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext